{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:28:50Z","timestamp":1760783330000,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ajem.2010.08.027","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T04:35:33Z","timestamp":1288067733000},"page":"1235.e5-1235.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hemodialysis as an alternative treatment of mexiletine intoxication"],"prefix":"10.1016","volume":"29","author":[{"given":"Emine","family":"Ak\u0131nc\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u00fccel","family":"Y\u00fczba\u015f\u0131oglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 3","key":"10.1016\/j.ajem.2010.08.027_bb0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.2003.054973","article-title":"Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.","volume":"554","author":"Wang","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.ajem.2010.08.027_bb0010","first-page":"498","article-title":"Antidysrhythmic agents toxicity","author":"Ellenhorn","year":"1997"},{"key":"10.1016\/j.ajem.2010.08.027_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM198701013160106","article-title":"Mexiletine","volume":"316","author":"Campbell","year":"1987","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajem.2010.08.027_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1254\/jphs.10012SC","article-title":"Mexiletine reverses oxaliplatin-induced neuropathic pain in rats","volume":"112","author":"Egashira","year":"2010","journal-title":"J Pharmacol Sci"},{"issue":"10 Suppl","key":"10.1016\/j.ajem.2010.08.027_bb0025","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"Am J Med"},{"issue":"18","key":"10.1016\/j.ajem.2010.08.027_bb0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0b013e3181dc1a3a","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","author":"Logigian","year":"2010","journal-title":"Neurology"},{"unstructured":"http:\/\/emedicine.medscape.com\/article\/813046-overview","key":"10.1016\/j.ajem.2010.08.027_bb0035"},{"key":"10.1016\/j.ajem.2010.08.027_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199937050-00002","article-title":"Clinical pharmacokinetics of mexiletine","volume":"37","author":"Labbe","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.ajem.2010.08.027_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0091270009341961","article-title":"Effects of mexiletine, a CYP1A2 inhibitor, on tizanidine pharmacokinetics and pharmacodynamics","volume":"50","author":"Momo","year":"2010","journal-title":"J Clin Pharmacol"},{"unstructured":"http:\/\/www.drugs.com\/pro\/mexiletine.html#ixzz0vcTequvB","key":"10.1016\/j.ajem.2010.08.027_bb0050"},{"issue":"6","key":"10.1016\/j.ajem.2010.08.027_bb0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jat\/18.6.354","article-title":"Postmortem distribution of mexiletine in a fatal overdose","volume":"18","author":"Rohrig","year":"1994","journal-title":"J Anal Toxicol"},{"issue":"2","key":"10.1016\/j.ajem.2010.08.027_bb0060","first-page":"18","article-title":"A case of fatal poisoning with the anti-arrhythmia agents Katen and Neo-Gilurytmal","volume":"42","author":"Petovsk\u00fd","year":"1997","journal-title":"Soud Lek"},{"issue":"6","key":"10.1016\/j.ajem.2010.08.027_bb0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jat\/18.6.346","article-title":"A mexiletine intoxication","volume":"18","author":"Kempton","year":"1994","journal-title":"J Anal Toxicol"},{"issue":"7956","key":"10.1016\/j.ajem.2010.08.027_bb0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(76)90272-5","article-title":"Letter: fatal mexiletine overdose","volume":"1","author":"Jequier","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2010.08.027_bb0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00609893","article-title":"Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis","volume":"24","author":"Wiegers","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2010.08.027_bb0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF03259923","article-title":"Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide","volume":"4","author":"Denaro","year":"1989","journal-title":"Med Toxicol Adverse Drug Exp"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675710004249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675710004249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:16:48Z","timestamp":1760023008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675710004249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0735675710004249"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2010.08.027","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemodialysis as an alternative treatment of mexiletine intoxication","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2010.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}